Clarus Wealth Advisors raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 12.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,744 shares of the financial services provider’s stock after buying an additional 1,047 shares during the quarter. Clarus Wealth Advisors’ holdings in iShares Biotechnology ETF were worth $1,212,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in IBB. Appleton Partners Inc. MA boosted its position in iShares Biotechnology ETF by 3.6% during the 2nd quarter. Appleton Partners Inc. MA now owns 64,618 shares of the financial services provider’s stock worth $8,204,000 after purchasing an additional 2,264 shares during the period. SG Americas Securities LLC boosted its stake in shares of iShares Biotechnology ETF by 2.2% in the second quarter. SG Americas Securities LLC now owns 31,493 shares of the financial services provider’s stock valued at $3,998,000 after purchasing an additional 685 shares during the period. Capital Market Strategies LLC purchased a new position in shares of iShares Biotechnology ETF in the second quarter valued at $335,000. Marotta Asset Management acquired a new position in iShares Biotechnology ETF in the 2nd quarter worth $402,000. Finally, Atomi Financial Group Inc. acquired a new position in iShares Biotechnology ETF in the 1st quarter worth $502,000. Hedge funds and other institutional investors own 69.61% of the company’s stock.
iShares Biotechnology ETF Stock Down 0.8 %
Shares of NASDAQ IBB traded down $0.97 during midday trading on Friday, reaching $126.61. 1,522,646 shares of the company’s stock were exchanged, compared to its average volume of 1,521,393. iShares Biotechnology ETF has a 52-week low of $113.37 and a 52-week high of $138.74. The business’s fifty day moving average price is $128.08 and its two-hundred day moving average price is $129.36.
About iShares Biotechnology ETF
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
- Five stocks we like better than iShares Biotechnology ETF
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- MarketBeat Week in Review – 9/11 – 9/15
- How Investors Can Identify and Successfully Trade Gap-Up Stocks
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.